Assessing RET-Altered Tumors for Personalized Oncology Care, Oct 23
Date: | 23-Oct-18 to 23-Oct-18 |
Location: | Hyatt Regency Chicago / Chicago / United States |
Category: | Healthcare & Pharmaceuticals Conferences & Trade Fairs |
Join us on Tuesday, October 23 at the Hyatt Regency in Chicago for a dynamic symposium during CAP 2018. Learn about the latest clinical data on selective RET inhibitors along with practical guidance to facilitate the detection of RET alterations from leading pathology experts, Dara L. Aisner, MD, PhD, and Eric Q. Konnick, MD, MS. They will lead discussions and answer your questions on the methodology and testing strategies for RET fusions and mutations.. This satellite symposium is complimentary to attend and is CME-certified for 1.5 contact hours.
Exhibitors
Dara L. Aisner, MD, PhD, Eric Q. Konnick, MD, MS
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Breastfeeding News Today
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- Pharmaceutical Industry Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- SARS News Today
- Wellness News Today